This uniformity among such variable ovarian cancer patients, including serous, endometrioid, as well as mucinous carcinoma, some of which were metastatic, strongly suggests the presence of a common homeostatic mechanism that governs the regulation of CD4+ and CD8+ T cell subset levels in patients. The gene discussed is CD8A; the disease is mucinous adenocarcinoma.